Hydroxyprogesterone caproate
Delalutin (hydroxyprogesterone caproate) is a small molecule pharmaceutical. Hydroxyprogesterone caproate was first approved as Hydroxyprogesterone caproate on 1982-01-01.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Hydroxyprogesterone caproate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| HYDROXYPROGESTERONE CAPROATE | Allergan | N-017439 DISCN | 1982-01-01 | 2 products |
| DELALUTIN | Bristol Myers Squibb | N-010347 DISCN | 1982-01-01 | 2 products, RLD |
| DELALUTIN | Bristol Myers Squibb | N-016911 DISCN | 1982-01-01 | 2 products, RLD |
| HYDROXYPROGESTERONE CAPROATE | Epic Pharma | N-018004 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| hydroxyprogesterone caproate | ANDA | 2022-06-22 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
Clinical
Clinical Trials
288 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 7 | 18 | 8 | 1 | 7 | 36 |
| Contraception | D003267 | — | — | 9 | 3 | 1 | 7 | 8 | 26 |
| Premature birth | D047928 | EFO_0003917 | O60 | 1 | 5 | 11 | 2 | 8 | 24 |
| Endometrial neoplasms | D016889 | EFO_0004230 | — | — | 9 | 3 | 1 | 1 | 12 |
| Infertility | D007246 | EFO_0000545 | — | — | — | 2 | 4 | 5 | 11 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 2 | 2 | 1 | 1 | 3 | 9 |
| Syndrome | D013577 | — | — | — | 1 | 1 | 1 | 4 | 7 |
| Endometrial hyperplasia | D004714 | — | N85.0 | — | 3 | 3 | 2 | — | 7 |
| Hiv | D006678 | — | O98.7 | — | 1 | — | 3 | 3 | 7 |
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | — | — | — | 2 | 4 | 6 |
Show 22 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 3 | 10 | 3 | — | — | 14 |
| Lymphoma | D008223 | — | C85.9 | 3 | 7 | 1 | — | 1 | 10 |
| Neoplasms | D009369 | — | C80 | 1 | 3 | 1 | — | 3 | 8 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | — | 1 | — | 7 | 8 |
| Menorrhagia | D008595 | EFO_0003945 | N92.0 | — | — | 4 | — | 2 | 6 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 1 | 6 | — | — | 6 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | 4 | — | — | 5 |
| Healthy volunteers/patients | — | — | — | 4 | 1 | 1 | — | — | 5 |
| Endometrioid carcinoma | D018269 | — | — | 1 | 3 | 1 | — | 1 | 5 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | 1 | 4 | — | 1 | 5 |
Show 49 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myelodysplastic syndromes | D009190 | — | D46 | 1 | 7 | — | — | 1 | 8 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 2 | 7 | — | — | 1 | 8 |
| Multiple myeloma | D009101 | — | C90.0 | 1 | 6 | — | — | 2 | 8 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 2 | 6 | — | — | 1 | 7 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | 6 | — | — | — | 6 |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 1 | 5 | — | — | 1 | 6 |
| Hodgkin disease | D006689 | — | C81 | 1 | 5 | — | — | — | 5 |
| Congenital adrenal hyperplasia | D000312 | — | E25.0 | 1 | 3 | — | — | 1 | 5 |
| Myelomonocytic leukemia juvenile | D054429 | — | C93.3 | — | 3 | — | — | — | 3 |
| Hematologic neoplasms | D019337 | — | — | 1 | 2 | — | — | 1 | 3 |
Show 31 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sickle cell anemia | D000755 | EFO_0000697 | D57 | 1 | — | — | — | 1 | 2 |
| Postcoital contraception | D044363 | — | — | 1 | — | — | — | 1 | 2 |
| Inborn genetic diseases | D030342 | EFO_0000508 | — | 1 | — | — | — | 1 | 2 |
| Disorders of sex development | D012734 | — | Q56.3 | 1 | — | — | — | 1 | 2 |
| Hepatitis c | D006526 | — | B19.2 | 2 | — | — | — | — | 2 |
| Churg-strauss syndrome | D015267 | EFO_0007208 | M30.1 | 1 | — | — | — | — | 1 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | — | — | — | — | 1 |
| Sarcoma | D012509 | — | — | 1 | — | — | — | — | 1 |
| Central nervous system neoplasms | D016543 | — | — | 1 | — | — | — | — | 1 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | — | — | — | — | 1 |
Show 28 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Intracranial aneurysm | D002532 | EFO_0003870 | I67.1 | — | — | — | — | 6 | 6 |
| Uterine hemorrhage | D014592 | — | — | — | — | — | — | 3 | 3 |
| Chronic pancreatitis | D050500 | EFO_0000342 | K86.1 | — | — | — | — | 3 | 3 |
| Pancreatic cyst | D010181 | — | K86.2 | — | — | — | — | 3 | 3 |
| Pancreatic ductal carcinoma | D021441 | — | — | — | — | — | — | 3 | 3 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | — | 2 | 2 |
| Vascular diseases | D014652 | EFO_0004264 | I77 | — | — | — | — | 2 | 2 |
| Aneurysm | D000783 | — | I72.9 | — | — | — | — | 2 | 2 |
| Bites and stings | D001733 | — | — | — | — | — | — | 2 | 2 |
| Periodontal diseases | D010510 | — | K05.6 | — | — | — | — | 1 | 1 |
Show 61 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Hydroxyprogesterone caproate |
| INN | hydroxyprogesterone caproate |
| Description | Hydroxyprogesterone caproate is a corticosteroid hormone. |
| Classification | Small molecule |
| Drug class | progestins; steroids (androgens, anabolics); antiandrogens |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CCCCCC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C |
Identifiers
| PDB | — |
| CAS-ID | 630-56-8 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1200848 |
| ChEBI ID | 5812 |
| PubChem CID | 169870 |
| DrugBank | DB06789 |
| UNII ID | 276F2O42F5 (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 7,893 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
23,105 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use